Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
31 8월 2023 - 6:22AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Schedule
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment
No. )
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary Proxy Statement |
|
|
☐ |
Confidential, for Use of the Commission Only (as permitted
by Rule 14a-6(e)(2)) |
|
|
☐ |
Definitive Proxy Statement |
|
|
☒ |
Definitive Additional Materials |
|
|
☐ |
Soliciting Material under § 240.14a-12 |
HILLSTREAM
BIOPHARMA, INC.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No fee required |
|
|
☐ |
Fee paid previously with preliminary materials. |
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b)
per Exchange Act Rules 14a- 6(i)(1) and 0-11 |
Hillstream BioPharma (NASDAQ:HILS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Hillstream BioPharma (NASDAQ:HILS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024